• OPEN AN ACCOUNT
Indian Indices
Sensex
76,863.71 -1,342.27
( -1.72%)
Global Indices
Nasdaq
47,431.94 -295.58
(-0.62%)
Dow Jones
6,795.43 -7.05
(-0.10%)
Hang Seng
55,018.23 769.84
(1.42%)
Nikkei 225
10,315.38 -96.86
(-0.93%)
Forex
USD-INR
92.14 0.30
(0.32%)
EUR-INR
106.58 -0.02
(-0.02%)
GBP-INR
123.09 0.04
(0.04%)
JPY-INR
0.58 0.00
(0.05%)

EQUITY - MARKET SCREENER

Swasti Vinayaka Synthetics Ltd
Industry :  Textiles - Spinning - Synthetic / Blended
BSE Code
ISIN Demat
Book Value()
510245
INE804A01025
2.5684333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
13.46
31.5
EPS(TTM)
Face Value()
Div & Yield %
0.26
1
0
 

algoquant fintech ltd
USFDA completes inspection of Enzene's manufacturing unit at Chakan, Pune
Feb 16,2026
Alkem Laboratories announced that the United States Food and Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) on 13 February, 2026 at the manufacturing facility of Enzene Biosciences (Enzene), a subsidiary of the Company in India located at Chakan, Pune.

At the conclusion of the inspection, the USFDA issued a Form 483 with 6 procedural observations. Enzene has achieved Zero observations related to data integrity – a critical validation of Enzene's quality systems and the reliability of regulatory filings.

Enzene is in the process of preparing and submitting its response to the USFDA within the stipulated timeline and has initiated appropriate corrective and preventive actions.